UAE becomes second country globally to approve use of first

Aduhelm is supplied as injections containing a dose of 100mlg. The drug is prescribed to patients with early stages of Alzheimer’s disease (mild cognitive impairment and mild dementia) by reducing amyloid beta plaques in the brain.

Related Keywords

Ministry Of Health , Dubayy , United Arab Emirates , Rachid Azar , Mohammed Al Owais , Paul Aisen , Al Owais , Health Prevention , Drug Administration , University Of Southern California , Alzheimer Therapeutic Research Institute , Accelerate Process , Rahman Bin Mohammed Al Owais , Health Minister , Executive Vice President , Cognitive Impairment Business Unit , Therapeutic Research Institute , Southern California , Covid 19 , Abu Dhabi News , Dubai News , Gulf News , , Latest News , News Today ,